| molecular function |
| | GO:0003723 | | RNA binding | | Interacting selectively and non-covalently with an RNA molecule or a portion thereof. |
| | GO:0003730 | | mRNA 3'-UTR binding | | Interacting selectively and non-covalently with the 3' untranslated region of an mRNA molecule. |
| | GO:0000900 | | translation repressor activity, nucleic acid binding | | Antagonizes the ribosome-mediated translation of mRNA into a polypeptide via direct binding (through a selective and non-covalent interaction) to nucleic acid. |
| biological process |
| | GO:0008595 | | anterior/posterior axis specification, embryo | | The specification of the anterior/posterior axis of the embryo by the products of genes expressed maternally and genes expressed in the zygote. |
| | GO:0048149 | | behavioral response to ethanol | | Any process that results in a change in the behavior of an organism as a result of an ethanol stimulus. |
| | GO:0001709 | | cell fate determination | | A process involved in cell fate commitment. Once determination has taken place, a cell becomes committed to differentiate down a particular pathway regardless of its environment. |
| | GO:0016477 | | cell migration | | The controlled self-propelled movement of a cell from one site to a destination guided by molecular cues. Cell migration is a central process in the development and maintenance of multicellular organisms. |
| | GO:0007268 | | chemical synaptic transmission | | The vesicular release of classical neurotransmitter molecules from a presynapse, across a chemical synapse, the subsequent activation of neurotransmitter receptors at the postsynapse of a target cell (neuron, muscle, or secretory cell) and the effects of this activation on the postsynaptic membrane potential and ionic composition of the postsynaptic cytosol. This process encompasses both spontaneous and evoked release of neurotransmitter and all parts of synaptic vesicle exocytosis. Evoked transmission starts with the arrival of an action potential at the presynapse. |
| | GO:0048813 | | dendrite morphogenesis | | The process in which the anatomical structures of a dendrite are generated and organized. A dendrite is a freely branching protoplasmic process of a nerve cell. |
| | GO:0007281 | | germ cell development | | The process whose specific outcome is the progression of an immature germ cell over time, from its formation to the mature structure (gamete). A germ cell is any reproductive cell in a multicellular organism. |
| | GO:0042078 | | germ-line stem cell division | | The self-renewing division of a germline stem cell to produce a daughter stem cell and a daughter germ cell, which will divide to form the gametes. |
| | GO:0008258 | | head involution | | Movement of the anterior ectoderm to the interior of the embryo. |
| | GO:0007616 | | long-term memory | | The memory process that deals with the storage, retrieval and modification of information a long time (typically weeks, months or years) after receiving that information. This type of memory is typically dependent on gene transcription regulated by second messenger activation. |
| | GO:0050804 | | modulation of chemical synaptic transmission | | Any process that modulates the frequency or amplitude of synaptic transmission, the process of communication from a neuron to a target (neuron, muscle, or secretory cell) across a synapse. Amplitude, in this case, refers to the change in postsynaptic membrane potential due to a single instance of synaptic transmission. |
| | GO:0007275 | | multicellular organism development | | The biological process whose specific outcome is the progression of a multicellular organism over time from an initial condition (e.g. a zygote or a young adult) to a later condition (e.g. a multicellular animal or an aged adult). |
| | GO:0045786 | | negative regulation of cell cycle | | Any process that stops, prevents or reduces the rate or extent of progression through the cell cycle. |
| | GO:0042059 | | negative regulation of epidermal growth factor receptor signaling pathway | | Any process that stops, prevents, or reduces the frequency, rate or extent of epidermal growth factor receptor signaling pathway activity. |
| | GO:0045892 | | negative regulation of transcription, DNA-templated | | Any process that stops, prevents, or reduces the frequency, rate or extent of cellular DNA-templated transcription. |
| | GO:0017148 | | negative regulation of translation | | Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| | GO:0000288 | | nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | | A major pathway of degradation of nuclear-transcribed mRNAs that proceeds through a series of ordered steps that includes poly(A) tail shortening and that can regulate mRNA stability. |
| | GO:0048477 | | oogenesis | | The complete process of formation and maturation of an ovum or female gamete from a primordial female germ cell. Examples of this process are found in Mus musculus and Drosophila melanogaster. |
| | GO:0007280 | | pole cell migration | | The directed movement of a pole cell (germline progenitors in insects) from its site of production at the posterior pole of the embryo through to the site where the gonads will form. |
| | GO:0060213 | | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | | Any process that increases the frequency, rate or extent of poly(A) tail shortening of a nuclear-transcribed mRNA. Poly(A) tail shortening is the decrease in length of the poly(A) tail of an mRNA from full length to an oligo(A) length. |
| | GO:0045727 | | positive regulation of translation | | Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| | GO:0016441 | | posttranscriptional gene silencing | | The inactivation of gene expression by a posttranscriptional mechanism. |
| | GO:0008582 | | regulation of synaptic growth at neuromuscular junction | | Any process that modulates the frequency, rate or extent of synaptic growth at neuromuscular junctions. |
| | GO:0006417 | | regulation of translation | | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| cellular component |
| | GO:0005737 | | cytoplasm | | All of the contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| | GO:0097482 | | muscle cell postsynaptic density | | A postsynaptic specialization that is part of a neuromuscular junction. |
| | GO:0031594 | | neuromuscular junction | | The junction between the axon of a motor neuron and a muscle fiber. In response to the arrival of action potentials, the presynaptic button releases molecules of neurotransmitters into the synaptic cleft. These diffuse across the cleft and transmit the signal to the postsynaptic membrane of the muscle fiber, leading to a change in post-synaptic potential. |
| | GO:0005635 | | nuclear envelope | | The double lipid bilayer enclosing the nucleus and separating its contents from the rest of the cytoplasm; includes the intermembrane space, a gap of width 20-40 nm (also called the perinuclear space). |
| | GO:0061176 | | type Ib terminal bouton | | Terminal inflated portion of the axon of a glutamatergic neuron, containing the specialized apparatus necessary for the tonic release neurotransmitters that will induce the contraction of muscle. Type Ib terminal boutons are larger than type Is terminal boutons. |
| | GO:0061177 | | type Is terminal bouton | | Terminal inflated portion of the axon of a glutamatergic neuron, containing the specialized apparatus necessary for the phasic release neurotransmitters that will induce the contraction of muscle. Type Is terminal boutons are smaller than type Ib terminal boutons. |